David A. Bennett

Physiology · 2002–2021

A researcher in the Science corpus: 43 papers; trusts 10 researchers and is trusted by 17 researchers here, as inferred from the citation graph.

Subfields

• Physiology — 264 citations into it; #314 of 2,276 by trust here, #31 by citations
• Psychiatry and Mental health — 204 citations into it; #73 of 1,338 by trust here, #15 by citations
• Neurology — 170 citations into it; #786 of 1,455 by trust here, #101 by citations
• Cognitive Neuroscience — 53 citations into it; #10,231 of 10,852 by trust here, #4,352 by citations
• Neuropsychology and Physiological Psychology — 5 citations into it; #284 of 305 by trust here, #84 by citations

Whom David A. Bennett trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. R. Wilson
2. Julie A. Schneider
3. Zoe Arvanitakis
4. Fergus I. M. Craik
5. Lisa L. Barnes
6. Jeffrey L. Cummings
7. Geert Verbeke
8. L. Beckett
9. Denis A. Evans
10. Clifford R. Jack Jr.

Who trusts David A. Bennett overall

1. Julie A. Schneider
2. R. Wilson
3. Zoe Arvanitakis
4. Peter Whitehouse
5. M. Levine
6. Aron S. Buchman
7. Ronald C. Petersen
8. A. Mitchell
9. Clifford R. Jack Jr.
10. Patricia A. Boyle

Papers from David A. Bennett's perspective

Ordered by how strongly the researchers David A. Bennett trusts endorse each paper. Same corpus, a different order for every researcher.

1. Alzheimer disease in the US population: prevalence estimates using the 2000 census. (Archives of Neurology)
2. Neuropathological stageing of Alzheimer-related changes
3. Rate of progression of mild cognitive impairment to dementia – meta‐analysis of 41 robust inception cohort studies (Acta Psychiatrica Scandinavica)
4. Natural history of mild cognitive impairment in older persons (Neurology)
5. Increased risk of type 2 diabetes in Alzheimer disease. (Diabetes)
6. Diet‐induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease (The FASEB Journal)
7. Participation in cognitively stimulating activities and risk of incident Alzheimer disease. (Journal of the American Medical Association (JAMA))
8. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers. (Journal of Clinical Investigation)
9. The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease (Journal of Neuroscience)
10. Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (Diabetes Care)

Their papers

• REST and Stress Resistance in Aging and Alzheimer’s Disease (2014) — 755 citations
• Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease (2013) — 1,668 citations
• Gene Expression Elucidates Functional Impact of Polygenic Risk for Schizophrenia (2016) — 1,080 citations
• Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease (2013) — 4,257 citations
• Charting a dynamic DNA methylation landscape of the human genome (2013) — 1,316 citations
• Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease (2011) — 1,887 citations
• Alzheimer disease in the US population: prevalence estimates using the 2000 census. (2003) — 2,364 citations
• Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. (2012) — 1,731 citations
• Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) — 2,422 citations
• The power of genetic diversity in genome-wide association studies of lipids (2021) — 765 citations
• Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation (2020) — 868 citations
• Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and - independent cellular responses in Alzheimer’s disease (2020) — 748 citations
• Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer’s disease (2020) — 614 citations
• Single-cell transcriptomic analysis of Alzheimer’s disease (2019) — 2,170 citations
• Associations of autozygosity with a broad range of human phenotypes (2019) — 112 citations
• Diagnosis and Management of Dementia: A Review (2019) — 1,153 citations
• Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function (2018) — 630 citations
• Religious Orders Study and Rush Memory and Aging Project (2018) — 1,113 citations
• A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers (2016) — 1,607 citations
• Genetic variants associated with subjective well-being, depressive symptoms and neuroticism identified through genome-wide analyses (2016) — 986 citations